<DOC>
	<DOCNO>NCT01863862</DOCNO>
	<brief_summary>In elderly patient postoperative mortality measure 3-6 month total mesorectal excision high . Thus , less toxic treatment may lead survival benefit elderly patient even risk local recurrence slightly high compare open surgery . The investigator address question whether watch wait policy safe clinical complete responder ( chemo ) radiation elderly patient small moderately advanced tumour .</brief_summary>
	<brief_title>Organ Preservation Elderly Patients With Rectal Cancer</brief_title>
	<detailed_description>There two step selection . In first step , elderly patient small moderately advanced tumour routinely receive neoadjuvant chemoradiation ( radiation alone unfit chemotherapy ) prior full-thickness local excision use transanal endoscopic microsurgery prior total mesorectal excision include . In next step , patient clinical complete response obtain 8-10 week completion ( chemo ) radiation select . Those patient constitute study group observe without treatment . The remain patient residual cancer proceed routine management , namely transanal endoscopic microsurgery total mesorectal excision . Patients undergoing transanal endoscopic microsurgery poor response ( chemo ) radiation ( ypT2-3 disease positive margin ) proceed conversion total mesorectal excision . Neoadjuvant chemoradiation : 50 Gy total dose 5 week 2 Gy per fraction deliver simultaneous chemotherapy consist three cycle 5-Fu 200 mg/m2 i.v . bolus leucovorin 100 mg/m2 i.v . short infusion 2 day give 1-2 , 15-16 , 29-30 day radiotherapy . Patients unfit chemotherapy receive 25 Gy total dose 5 day 5 Gy per fraction . The study hypothesis clinical complete responder ( chemo ) radiation treat without initial surgery , local recurrence rate le 25 % result rescue surgery ( local distant recurrence rate ) worse ( slightly bad ) see up-front total mesorectal excision patient similar stage disease .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>The initial eligibility criterion Age ≥70 year &lt; 70 year patient ASA 3+ Tumour accessible digital rectal examination Maximal tumour size ( usually length ) 5 cm Circumferential bowel wall involvement large 60 % There two group patient : 1 . Candidates preoperative ( chemo ) radiotherapy local excision : tumour ≤3 cm , nonpolipoid cT1 , cT2 borderline cT3 , cN0 . 2 . Candidates preoperative ( chemo ) radiotherapy total mesorectal excision : cT2 tumor require abdominoperineal excision , cT3 resectable cT4 ( slight involvement vagina , prostate seminal vesicle ) ; cN+ allow . The final eligibility criterion • Complete clinical response obtain 8 week chemoradiation 10 week shortcourse radiation Distant metastases Fixed tumour digital rectal examination</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Rectal cancer</keyword>
	<keyword>Chemoradiation</keyword>
	<keyword>Complete pathological response</keyword>
</DOC>